Clinical Trials Browser

Phase 2 × Glioblastoma × Bortezomib × Clear all

NCT00998010 2020-08-28

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2 Completed

24 enrolled 10 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00641706 2014-05-14

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

Phase 2 Completed

44 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00611325 2014-03-12

Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma

Phase 2 Completed

56 enrolled 11 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma